Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.020 SEK
5.39 M SEK
2.81 M SEK
106.46 M
About KAROLINSKA DEVELOPMENT AB SER.B
Sector
Industry
CEO
Viktor Drvota
Website
Headquarters
Solna
Founded
2006
ISIN
SE0002190926
FIGI
BBG001MKRLW7
Karolinska Development AB engages in the investment in pharmaceutical and medical technology companies. Its portfolio investments include Umecrine Cognition, Forendo Pharma, OssDsign, Modus Therapeutics, Dilafor, Aprea Therapeutics, Lipidor, Promimic, and Asarina Pharma. The company was founded in 2003 and is headquartered in Solna, Sweden.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of KDEV is 1.168 SEK — it has decreased by −3.31% in the past 24 hours. Watch KAROLINSKA DEVELOPMENT AB SER.B stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange KAROLINSKA DEVELOPMENT AB SER.B stocks are traded under the ticker KDEV.
KDEV stock has fallen by −3.47% compared to the previous week, the month change is a −0.85% fall, over the last year KAROLINSKA DEVELOPMENT AB SER.B has showed a −24.16% decrease.
KDEV reached its all-time high on Apr 15, 2011 with the price of 38.078 SEK, and its all-time low was 1.100 SEK and was reached on Nov 7, 2024. View more price dynamics on KDEV chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
KDEV stock is 7.66% volatile and has beta coefficient of 0.12. Track KAROLINSKA DEVELOPMENT AB SER.B stock price on the chart and check out the list of the most volatile stocks — is KAROLINSKA DEVELOPMENT AB SER.B there?
Today KAROLINSKA DEVELOPMENT AB SER.B has the market capitalization of 315.17 M, it has increased by 2.03% over the last week.
Yes, you can track KAROLINSKA DEVELOPMENT AB SER.B financials in yearly and quarterly reports right on TradingView.
KAROLINSKA DEVELOPMENT AB SER.B is going to release the next earnings report on Nov 15, 2024. Keep track of upcoming events with our Earnings Calendar.
KDEV net income for the last quarter is −15.99 M SEK, while the quarter before that showed 208.00 K SEK of net income which accounts for −7.79 K% change. Track more KAROLINSKA DEVELOPMENT AB SER.B financial stats to get the full picture.
No, KDEV doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KAROLINSKA DEVELOPMENT AB SER.B EBITDA is −12.99 M SEK, and current EBITDA margin is −39.65%. See more stats in KAROLINSKA DEVELOPMENT AB SER.B financial statements.
Like other stocks, KDEV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KAROLINSKA DEVELOPMENT AB SER.B stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KAROLINSKA DEVELOPMENT AB SER.B technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KAROLINSKA DEVELOPMENT AB SER.B stock shows the sell signal. See more of KAROLINSKA DEVELOPMENT AB SER.B technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.